Pregnancy outcome after exposure to injectable ribavirin during embryogenesis
- PMID: 16122903
- PMCID: PMC7134815
- DOI: 10.1016/j.reprotox.2005.06.005
Pregnancy outcome after exposure to injectable ribavirin during embryogenesis
Abstract
We describe normal pregnancy outcome in a case of first trimester exposure to injectable ribavirin in a 36-year-old pregnant woman who received three intramuscular injections of ribavirin for suspected SARS. She delivered at 40 weeks of gestation a healthy baby girl. In pediatric follow up at 8 month of age, physical examination and neurodevelopmental milestones were normal.
References
-
- Kochhar D.M., Penner J.D., Knudsen T.B. Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice. Toxicol Appl Pharmacol. 1980;52:99–112. - PubMed
-
- Johnson E.M. The effects of ribavirin on development and reproduction: a critical review of published and unpublished studies. Endocrinology. 1990;131:1149–1156.
-
- Ito S., Koren G. Exposure of pregnant women to ribavirin-contaminated air: risk assessment and recommendations. Pediatr Infect Dis J. 1993;12:2–5. - PubMed
-
- Glue P. The clinical pharmacology of ribavirin. Semin Liver Dis. 1999;19:17–24. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
